Clinical trial
A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)
NCT00104364 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00104364 |
|---|---|
| Title | A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) |
| Official title | An Open-label, Dose Escalation Phase I/II Trial of a KSP Inhibitor Given as a Constant 24-Hour Infusion in Patients With Advanced Solid Tumors |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | MK0731 |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Feb 28, 2005 |
| Last update posted | Jan 30, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: